FBRX Stock Analysis: Buy, Sell, or Hold?
FBRX - Forte Biosciences, Inc. Common Stock
$76.95
0.03 (0.04%)
â˛
5d:
+0.08%
30d:
+40.47%
90d:
+256.42%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When FBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: FBRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: FBRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: FBRX is currently trading at $76.95, which is considered slightly high relative to its 30-day fair value range of $59.50 to $81.61.
Technical Outlook: Technically, FBRX is in a strong uptrend. The price is currently testing key support at $76.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FBRX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBRX is in a strong uptrend. The price is currently testing key support at $76.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FBRX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$59.50 -
$81.61
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
36.8%
All Signals
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($73.80)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$59.50 -
$81.61
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$76.76
Resistance Level
$76.95
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.51
Wall Street Target
$73.80
(-4.1%)
Share & Embed Analysis
Last updated: August 24, 2026 11:15 PM ET
Data refreshes hourly during market hours. Next update: 12:15 AM
Data refreshes hourly during market hours. Next update: 12:15 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 47 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 43 HOLD |
|
EYPT
EyePoint, Inc |
STRONG BUY
13 analysts |
$27 | 49 HOLD |
